Date Modified

2019-07-09

Period

6/months

Report Summary

The mean age of the study participants was 52±11 years. The improvement of mean HbA1c from baseline to 3-months follow-up, the intervention (baseline: 9.7% ± 1.3, follow-up: 8.2% ±1.0, p =0.001) and control (baseline: 9.5%±1.6, follow-up: 8.2%±0.6, p=0.008) arms were not significantly different (p=0.98). However, a significant improvement in HbA1c was observed in the intervention arm from 3months (8.3%±0.6) to 6-months (7.3%±0.6), (p=0.005) compared with the control arm (8.2% at 3-months) (7.9%±0.6 at 6-months), (p=0.16). Improvement of mean HbA1c was shown in both arms 3-months after the baseline clinic visit, but after 6months, only the intervention arm continued to show statistically significant improvement of HbA1c (p=0.01).

Attached file